FOURTH EXTENSION - GRANTED
granted
on 04 Dec 2024
Last Applicant/ Owned by
6 Tide St
Boston
MA
02210
Serial Number
90795540 filed on 25th Jun 2021
Registration Number
N/A
Correspondent Address
Perry J. Viscounty
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
JNANA THERAPEUTICS
Pharmaceutical preparations that modulate historically undruggable targets across target classes, namely, solute carrier (SLC) metabolite transporters, transcription factors, signaling scaffolds and phosphatases for the treatment of rare, autoimmune and inflammatory diseases and cancer
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations that modulate historically undruggable targets across target classes, namely, solute carrier (SLC) metabolite transporters, transcription factors, signaling scaffolds and phosphatases for the treatment of rare, autoimmune and inflammatory diseases and cancer
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 90795540
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 061138-0012
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 05th Dec 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 05th Dec 2024 | SOU EXTENSION 4 GRANTED |
| 25th Nov 2024 | SOU TEAS EXTENSION RECEIVED |
| 25th Nov 2024 | SOU EXTENSION 4 FILED |
| 21st Jun 2024 | SOU EXTENSION 3 GRANTED |
| 21st Jun 2024 | SOU EXTENSION 3 FILED |
| 21st Jun 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 21st Jun 2024 | SOU TEAS EXTENSION RECEIVED |
| 09th Dec 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 07th Dec 2023 | SOU EXTENSION 2 GRANTED |